← All trials
NCT01470651
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2011
- Primary completion
- Jun 1, 2014
- Completion date
- Jun 1, 2014
- First posted
- —
- Last posted
- —
- Enrollment
- 26
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Research Foundation for Mental Hygiene, Inc.Lead sponsor
- Cornell UniversityOverall official - principal investigator
- Cornell UniversityCollaborator
- Research Foundation for Mental Hygiene, Inc.Reponsible party - principal investigator
- Icahn School of Medicine at Mount SinaiOverall official - principal investigator
- Icahn School of Medicine at Mount SinaiCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.